Wirk, Baldeep, and Jin Lim. “Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma”. Journal of Hematology (April 22, 2025). Accessed April 25, 2025. https://jh.elmerpub.com/jh/article/view/2046.